, Johannes Ridinger , via Toll-like Receptor Signaling CellsInflammatory Cytokines in Monocytic Body Fluid Exosomes Promote Secretion of Signal Transduction

[1]  S. Akyol.  Retraction: Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling , 2015, The Journal of Immunology.

[2]  Hong-Jian Zhu,et al.  Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components , 2013, Proteomics.

[3]  J. Wrana,et al.  Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration , 2012, Cell.

[4]  Abhishek D. Garg,et al.  Immunogenic cell death and DAMPs in cancer therapy , 2012, Nature Reviews Cancer.

[5]  J. Minárovits,et al.  Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro. , 2012, Immunology letters.

[6]  Veronica Huber,et al.  Recent advances on the role of tumor exosomes in immunosuppression and disease progression. , 2012, Seminars in cancer biology.

[7]  Roberta Galli,et al.  MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.

[8]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[9]  A. Clayton.  Cancer cells use exosomes as tools to manipulate immunity and the microenvironment , 2012, Oncoimmunology.

[10]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[11]  Holger Sültmann,et al.  Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. , 2011, Gynecologic oncology.

[12]  Ç. Gerçel-Taylor,et al.  Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments , 2011, Seminars in Immunopathology.

[13]  P. Altevogt,et al.  Body fluid derived exosomes as a novel template for clinical diagnostics , 2011, Journal of Translational Medicine.

[14]  O. De Wever,et al.  An ex(o)citing machinery for invasive tumor growth. , 2010, Cancer research.

[15]  Aled Clayton,et al.  Cancer exosomes trigger fibroblast to myofibroblast differentiation. , 2010, Cancer research.

[16]  Luigi Biancone,et al.  Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.

[17]  W. Grizzle,et al.  TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes. , 2010, The American journal of pathology.

[18]  T. Whiteside,et al.  Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg) , 2010, PloS one.

[19]  L. Zitvogel,et al.  Dendritic cell-derived exosomes for cancer immunotherapy: what's next? , 2010, Cancer research.

[20]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[21]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[22]  P. Altevogt,et al.  Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. , 2009, Cancer letters.

[23]  A. Poliakov,et al.  Induction of myeloid‐derived suppressor cells by tumor exosomes , 2009, International journal of cancer.

[24]  P. Altevogt,et al.  Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/γ-secretase activity , 2009, The Biochemical journal.

[25]  Cicek Gercel-Taylor,et al.  MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.

[26]  M. Mason,et al.  Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression1 , 2008, The Journal of Immunology.

[27]  G. Kristiansen,et al.  Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. , 2007, Gynecologic oncology.

[28]  P. Altevogt,et al.  CD24 is a marker of exosomes secreted into urine and amniotic fluid. , 2007, Kidney international.

[29]  Aled Clayton,et al.  Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. , 2007, Cancer research.

[30]  H. Valadi,et al.  Cell to Cell Signalling via Exosomes Through esRNA , 2007, Cell adhesion & migration.

[31]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[32]  William E. Grizzle,et al.  Tumor Exosomes Inhibit Differentiation of Bone Marrow Dendritic Cells1 , 2007, The Journal of Immunology.

[33]  G. Parmiani,et al.  Tumor-released microvesicles as vehicles of immunosuppression. , 2007, Cancer research.

[34]  Sascha Keller,et al.  Exosomes: from biogenesis and secretion to biological function. , 2006, Immunology letters.

[35]  A. Villa,et al.  Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. , 2006, Cancer research.

[36]  P. Altevogt,et al.  A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. , 2006, The Biochemical journal.

[37]  R. Jove,et al.  Stat3 regulates genes common to both wound healing and cancer , 2005, Oncogene.

[38]  T. Whiteside,et al.  Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system? , 2005, British Journal of Cancer.

[39]  H. Stenmark,et al.  Protein sorting into multivesicular endosomes. , 2003, Current opinion in cell biology.

[40]  M. Bianchi,et al.  The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.

[41]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[42]  L. Zitvogel,et al.  Malignant effusions and immunogenic tumour-derived exosomes , 2002, The Lancet.

[43]  Graça Raposo,et al.  The Biogenesis and Functions of Exosomes , 2002, Traffic.

[44]  F. Saladino,et al.  The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. , 1998, Anticancer research.

[45]  B. Chauffert,et al.  Membrane-associated Hsp 72 from tumor-derived exosomes mediates STAT 3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells , 2010 .

[46]  Miguel C. Seabra,et al.  Rab27a and Rab27b control different steps of the exosome secretion pathway , 2010, Nature Cell Biology.

[47]  Miguel C. Seabra,et al.  1 Rab 27 a and Rab 27 b control different steps of the exosome secretion pathway , 2009 .